|
|
||||
|
|
||||
|
||||
Abstract.
On the heels of widespread patient protection legislation in the states, the managed care industry abandoned or greatly scaled back the core elements of gatekeeping, utilization management, and financial incentives, which are the very targets of this legislation. This article explores whether, and to what extent, the industry's abrupt change in course can be attributed to these laws. Based on extensive interviews with key informants in six representative states, the article concludes that these laws were not the primary driver of changes in managed care practices. However, patient protection laws interacted with other social and market forces, through complex forms of feedback and reinforcement, to bring about more thoroughgoing change than would have otherwise occurred.
This article has been cited by other articles:
![]() |
K. Kronebusch, M. Schlesinger, and T. Thomas Managed Care Regulation in the States: The Impact on Physicians' Practices and Clinical Autonomy Journal of Health Politics Policy and Law, April 1, 2009; 34(2): 219 - 259. [Abstract] [PDF] |
||||
![]() |
V. Gray, D. Lowery, and E. K. Godwin The Political Management of Managed Care: Explaining Variations in State Health Maintenance Organization Regulations Journal of Health Politics Policy and Law, June 1, 2007; 32(3): 457 - 495. [Abstract] [PDF] |
||||
![]() |
V. Gray, D. Lowery, and E. K. Godwin Public Preferences and Organized Interests in Health Policy: State Pharmacy Assistance Programs as Innovations Journal of Health Politics Policy and Law, February 1, 2007; 32(1): 89 - 129. [Abstract] [PDF] |
||||
![]() |
D. P. Sulmasy Cancer Care, Money, and the Value of Life: Whose Justice? Which Rationality? J. Clin. Oncol., January 10, 2007; 25(2): 217 - 222. [Abstract] [Full Text] [PDF] |
||||
|
|